ProCE Banner Activity

Overview of the BCR Pathway and Use of BTK Inhibitors in CLL

Slideset Download
Download this slideset from Ian Flinn, MD, PhD to review the rational and overview of the data on the use of BTK inhibitors for patients with CLL.

Released: December 04, 2020

Expiration: December 03, 2021

Share

Faculty

Ian Flinn

Ian Flinn, MD, PhD

Chief Scientific Officer
OneOncology
Nashville, Tennessee

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

BeiGene, Ltd.

Faculty Disclosure

Primary Author

Ian Flinn, MD, PhD

Chief Scientific Officer
OneOncology
Nashville, Tennessee